Scientific writing and advisory work translates complex data into precise documents that withstand peer review, regulatory scrutiny, and executive decision-making. Each engagement is anchored to a clear question, a documented method, defined outputs, and a disciplined review cycle. Assignments are delivered in English for organisations across Europe and beyond.
Medical writing covers manuscripts for peer-reviewed journals, book chapters, and clinical or observational study documents. Protocol language and statistical analysis plan wording are prepared with biostatistics. Reporting follows journal instructions and relevant standards, including CONSORT for trials and PRISMA for reviews. Figures, tables, and supplementary materials are built from source data with traceable references and permissions.
Regulatory communication includes clinical and non-clinical summaries aligned with ICH expectations (e.g., E3, E6(R2)), structured reports for health authorities, briefing packages, and responses to information requests. The emphasis is clarity, internal consistency, and traceability from narrative to tables and appendices. Terminology is harmonised across modules, and assumptions are stated so reviewers can follow the reasoning.
Evidence synthesis and scientific advisory services provide decision-ready analysis for pipeline, clinical strategy, and diligence. Work begins with predefined search strings and screening rules, followed by data extraction and bias assessment using established frameworks. Outputs include targeted or systematic reviews and decision briefs with options and trade-offs. Search strategies, selection flow, and citation sets are archived for audit.
Environmental and toxicology assessment addresses exposure characterisation and risk evaluation for chemicals and ingredients. Deliverables include technical memoranda and executive summaries that set out exposure ranges, hazard data, margins of safety, and uncertainty. References to authoritative bodies are cited explicitly, and calculation steps are preserved for verification by internal and external stakeholders.
Executive and stakeholder communication turns technical results into concise materials for leadership, investors, and corporate affairs. White papers, board briefings, and presentation decks present the question, the evidence, the rationale, and the implications in a format suited to time-constrained review while retaining scientific precision.
Typical deliverables include a Word manuscript or PDF report, an optional slide deck, editable vector figures, and a managed bibliography. Draft one is provided on the agreed date with tracked changes and a comment log explaining key decisions. One focused revision round is included to reach final approval. Accelerated schedules are possible when inputs are complete and reviewers are available. Work integrates with document control and security requirements and aligns with good-practice standards used by clinical, regulatory, medical affairs, and R&D teams.
For scoping, share the objective, audience, deadline, applicable standards, and confidentiality requirements. A written proposal will define the method, deliverables, schedule, and pricing as fixed or capped, with milestones that match internal governance.